Michael Knell, Anthony Mattacchione
Bruker VP of Finance and Chief Accounting Officer Michael Knell announced he is resigning from the firm, effective April 21, in order to pursue other opportunities. Bruker CFO and Senior VP Anthony Mattacchione has assumed Knell's responsibilities as the company's principal accounting officer.
Anthony Gregg, Laurie Demmer, Elaine Lyon, Catherine Rehder
The American College of Medical Genetics has appointed Anthony Gregg as president-elect, Laurie Demmer as clinical genetics director, Elaine Lyon as laboratory molecular genetics director, and Catherine Rehder as laboratory cytogenetics director. It has also appointed Gregg, Demmer, Lyon, and Rehder to its board of directors. Gregg is currently a professor and chief of maternal-fetal medicine at the University of Florida. He also serves as the director of obstetrics at UF Health and program director of the Maternal-Fetal Medicine Fellowship. Demmer is a clinical geneticist and associate pediatric residency program director at Levine Children's Hospital/Carolinas Health Care. Lyon is currently a tenured professor of pathology at the University of Utah, and serves as chair of the departmental academic committee responsible for the department's faculty appointment. Rehder is currently the director of Duke University's Cytogenetics Laboratory and associate director of the Duke Molecular Diagnostics Laboratory.
Nicolas Barthelemy, Carlos Paya
Fluidigm said this week that it has appointed Nicolas Barthelemy and Carlos Paya to its board of directors. Barthelemy most recently served as president and CEO of molecular diagnostics firm Biotheranostics. He previously served as president of global commercial operations at Life Technologies and has also led the firm's cell systems division. He also serves on the board of directors of Repligen. Paya is president, CEO, and director of immunotherapy firm Immune Design. He formerly served as president of pharmaceutical firm Elan, and was VP of Lilly Research Laboratories.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.